There is no single test that confirms reactive arthritis. Diagnosis relies on a combination of your symptom pattern, evidence of a recent infection, blood work, and sometimes imaging or joint fluid analysis. The American College of Rheumatology’s diagnostic guidelines use two major criteria: asymmetric arthritis in the lower extremities, and a gut or urogenital infection that occurred 3 days to 6 weeks before the joint symptoms began.
The Symptom Pattern Matters Most
Reactive arthritis is fundamentally a clinical diagnosis, meaning your history and physical exam carry more weight than any lab result. The classic presentation is a triad of joint inflammation, urinary tract symptoms, and eye inflammation (conjunctivitis or uveitis). Not everyone develops all three, but when they occur together after a recent infection, the pattern is distinctive.
The joint involvement is typically asymmetric, affecting one to a few joints rather than many, and favors the knees, ankles, and feet. Swelling of an entire toe or finger (sometimes called “sausage digit”) is another hallmark. Symptoms typically start 1 to 4 weeks after the triggering infection. That timeline is a key diagnostic clue: if you develop joint pain within a month of a bout of diarrhea or a genital infection, that connection matters. Skin changes can also point toward the diagnosis, including painless sores on the palms or soles and small ulcers in the mouth.
Blood Tests for Inflammation
Standard blood work helps confirm that inflammation is present, though it can’t pinpoint reactive arthritis specifically. The two main markers are the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). ESR measures how quickly red blood cells settle in a tube, with normal values generally under 20 mm/hr for men and under 30 mm/hr for women over 50. CRP, which rises and falls more quickly with active inflammation, is normally below 1.0 mg/L. Elevated levels of either marker support the idea that something inflammatory is happening in your body, but they don’t distinguish reactive arthritis from other causes.
Importantly, rheumatoid factor (RF) and anti-CCP antibodies are usually checked too, not because they’re expected to be positive, but because negative results help rule out rheumatoid arthritis. Reactive arthritis is seronegative, meaning these autoantibodies are absent. A positive RF or anti-CCP would steer the diagnosis in a different direction.
Testing for the Triggering Infection
Because reactive arthritis is, by definition, triggered by an infection, confirming which pathogen was involved strengthens the diagnosis considerably. The most common culprits fall into two categories: sexually transmitted infections (primarily chlamydia) and foodborne bacteria (Salmonella, Shigella, Campylobacter, and Yersinia).
For chlamydia, a urine test or urethral/cervical swab using PCR (a highly sensitive DNA-detection method) is standard. PCR testing of joint fluid for chlamydia DNA, when available, is considered strongly diagnostic. For gastrointestinal triggers, stool cultures can identify Salmonella, Shigella, or Campylobacter, though the original infection may have already cleared by the time arthritis appears. In those cases, antibody blood tests for these bacteria can sometimes confirm a recent exposure even after the gut symptoms have resolved.
Confirming the infection counts as a minor criterion in the ACR diagnostic guidelines. Culture positivity doesn’t have to be present for diagnosis, but when it is, it adds significant confidence.
The HLA-B27 Genetic Test
HLA-B27 is a genetic marker found on the surface of white blood cells that is strongly linked to reactive arthritis and other inflammatory spinal conditions. A simple blood test can detect it. Around 50% of people with Salmonella-, Campylobacter-, or chlamydia-triggered reactive arthritis carry this marker, while the figure rises to roughly 80% in cases triggered by Shigella. People who are HLA-B27 positive are five times more likely to develop reactive arthritis than the general population.
Testing positive doesn’t confirm the diagnosis on its own, since about 6 to 8% of the general population carries HLA-B27 without ever developing problems. But combined with the right symptoms, elevated inflammatory markers, and evidence of a triggering infection, a positive HLA-B27 result brings the diagnostic picture into sharper focus. When genitourinary symptoms, involvement of the ball-of-foot joints, elevated CRP, and positive HLA-B27 are all present together, the combination has 69% sensitivity and 93.5% specificity for reactive arthritis. HLA-B27 positivity also signals a higher risk for chronic or relapsing disease, uveitis, and spinal involvement.
Joint Fluid Analysis
If a joint is significantly swollen, your doctor may draw fluid from it with a needle. This serves two purposes: relief from pressure and diagnostic information. In reactive arthritis, the fluid is typically inflammatory, with elevated white blood cell counts and a predominance of a specific type of immune cell called neutrophils. Crucially, though, the fluid should be sterile on standard bacterial culture. If bacteria are growing directly in the joint fluid, that points to septic arthritis, a more dangerous condition requiring urgent antibiotics.
The distinction between septic and reactive arthritis is one of the most important reasons for joint aspiration. Septic arthritis usually produces white blood cell counts above 50,000 cells per microliter in the joint fluid, along with high fever, severe pain, and a red, hot joint. Reactive arthritis causes lower cell counts and, while painful, doesn’t typically produce the same acute toxicity. When the diagnosis is uncertain, watching the response to antibiotics over 48 hours can also help clinicians tell the two apart.
Imaging: Ultrasound and MRI
Imaging isn’t always necessary for diagnosis, but it can reveal inflammation that isn’t obvious on physical exam. Ultrasound is particularly useful for detecting enthesitis, which is inflammation where tendons and ligaments attach to bone. This is a hallmark of reactive arthritis and related conditions. On ultrasound, enthesitis appears as thickening and darkening of the tendon insertion, sometimes with increased blood flow visible on Doppler imaging. Ultrasound can also pick up fluid collections in bursae and subtle joint swelling.
MRI provides a more detailed look and is especially helpful for evaluating the sacroiliac joints at the base of the spine. The characteristic MRI finding is bone marrow swelling (edema) adjacent to the enthesis, along with surrounding soft tissue inflammation. X-rays are less sensitive in early disease but may show joint space changes or erosions in cases that have persisted for months.
How the Pieces Fit Together
No single test result makes or breaks the diagnosis. Instead, your doctor assembles a picture from multiple sources. The ACR guidelines organize this into major criteria (asymmetric lower extremity arthritis plus a preceding infection) and minor criteria (positive infection cultures, persistent joint inflammation, urinary symptoms, ball-of-foot joint involvement, elevated CRP, and HLA-B27 positivity). Meeting the major criteria with supporting minor findings is the standard pathway to diagnosis.
In practice, testing usually unfolds in stages. The first step is blood work for inflammatory markers, RF, anti-CCP, and HLA-B27. Simultaneously, infection screening targets chlamydia (urine PCR) and enteric bacteria (stool culture or serologies). If a joint is swollen enough, fluid is drawn to rule out septic arthritis and gout. Imaging is added when enthesitis or sacroiliac involvement is suspected. The entire process can often be completed within a few office visits, though some results, particularly HLA-B27 and specialized cultures, may take a week or more to return.